Management of abnormal bleeding in the adolescent

Julie Jaffray, Kristina Haley

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heavy menstrual bleeding is the most common sign of an acquired or inherited bleeding disorder in females. For many young women, the manifestations of an inherited bleeding disorder do not surface until menarche, which can lead to a delay in diagnosis. Besides heavy menstrual bleeding, patients can have menstrual pain from bleeding into the corpus luteum, bleeding from trauma or procedures, easy bruising, and gastrointestinal bleeding. An undiagnosed bleeding disorder can lead to severe blood loss, chronic iron deficiency, and unnecessary surgical procedures, such as a hysterectomy. Therefore, identifying a possible bleeding disorder in these young women is crucial to allow an initiation of targeted therapy. Management of bleeding will depend on the diagnosis, as well as the severity and bleeding location. Many adolescent females with menorrhagia can be successfully managed with a combination of hormonal control and/or antifibrinolytics. Depending on the diagnosis, treatment can also include coagulation factor replacement, blood product transfusion, as well as specific therapies for acquired bleeding disorders, such as intravenous immune globulin, plasmapheresis, or corticosteroids.

Original languageEnglish (US)
Title of host publicationHandbook of Gynecology
PublisherSpringer International Publishing
Pages121-134
Number of pages14
Volume1
ISBN (Electronic)9783319177984
ISBN (Print)9783319177977
DOIs
StatePublished - Aug 28 2017

Fingerprint

Hemorrhage
Unnecessary Procedures
Menorrhagia
Dysmenorrhea
Antifibrinolytic Agents
Menarche
Blood Coagulation Factors
Plasmapheresis
Intravenous Immunoglobulins
Corpus Luteum
Hysterectomy
Blood Transfusion
Adrenal Cortex Hormones
Therapeutics
Iron
Wounds and Injuries

Keywords

  • Adolescent
  • Factor deficiency
  • Hemophilia carrier
  • ITP
  • Menorrhagia
  • Platelet dysfunction
  • TTP
  • Von willebrand disease
  • VWD

ASJC Scopus subject areas

  • Medicine(all)
  • Health Professions(all)

Cite this

Jaffray, J., & Haley, K. (2017). Management of abnormal bleeding in the adolescent. In Handbook of Gynecology (Vol. 1, pp. 121-134). Springer International Publishing. https://doi.org/10.1007/978-3-319-17798-4_84

Management of abnormal bleeding in the adolescent. / Jaffray, Julie; Haley, Kristina.

Handbook of Gynecology. Vol. 1 Springer International Publishing, 2017. p. 121-134.

Research output: Chapter in Book/Report/Conference proceedingChapter

Jaffray, J & Haley, K 2017, Management of abnormal bleeding in the adolescent. in Handbook of Gynecology. vol. 1, Springer International Publishing, pp. 121-134. https://doi.org/10.1007/978-3-319-17798-4_84
Jaffray J, Haley K. Management of abnormal bleeding in the adolescent. In Handbook of Gynecology. Vol. 1. Springer International Publishing. 2017. p. 121-134 https://doi.org/10.1007/978-3-319-17798-4_84
Jaffray, Julie ; Haley, Kristina. / Management of abnormal bleeding in the adolescent. Handbook of Gynecology. Vol. 1 Springer International Publishing, 2017. pp. 121-134
@inbook{9417c9239c664be7a648045d4914416e,
title = "Management of abnormal bleeding in the adolescent",
abstract = "Heavy menstrual bleeding is the most common sign of an acquired or inherited bleeding disorder in females. For many young women, the manifestations of an inherited bleeding disorder do not surface until menarche, which can lead to a delay in diagnosis. Besides heavy menstrual bleeding, patients can have menstrual pain from bleeding into the corpus luteum, bleeding from trauma or procedures, easy bruising, and gastrointestinal bleeding. An undiagnosed bleeding disorder can lead to severe blood loss, chronic iron deficiency, and unnecessary surgical procedures, such as a hysterectomy. Therefore, identifying a possible bleeding disorder in these young women is crucial to allow an initiation of targeted therapy. Management of bleeding will depend on the diagnosis, as well as the severity and bleeding location. Many adolescent females with menorrhagia can be successfully managed with a combination of hormonal control and/or antifibrinolytics. Depending on the diagnosis, treatment can also include coagulation factor replacement, blood product transfusion, as well as specific therapies for acquired bleeding disorders, such as intravenous immune globulin, plasmapheresis, or corticosteroids.",
keywords = "Adolescent, Factor deficiency, Hemophilia carrier, ITP, Menorrhagia, Platelet dysfunction, TTP, Von willebrand disease, VWD",
author = "Julie Jaffray and Kristina Haley",
year = "2017",
month = "8",
day = "28",
doi = "10.1007/978-3-319-17798-4_84",
language = "English (US)",
isbn = "9783319177977",
volume = "1",
pages = "121--134",
booktitle = "Handbook of Gynecology",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Management of abnormal bleeding in the adolescent

AU - Jaffray, Julie

AU - Haley, Kristina

PY - 2017/8/28

Y1 - 2017/8/28

N2 - Heavy menstrual bleeding is the most common sign of an acquired or inherited bleeding disorder in females. For many young women, the manifestations of an inherited bleeding disorder do not surface until menarche, which can lead to a delay in diagnosis. Besides heavy menstrual bleeding, patients can have menstrual pain from bleeding into the corpus luteum, bleeding from trauma or procedures, easy bruising, and gastrointestinal bleeding. An undiagnosed bleeding disorder can lead to severe blood loss, chronic iron deficiency, and unnecessary surgical procedures, such as a hysterectomy. Therefore, identifying a possible bleeding disorder in these young women is crucial to allow an initiation of targeted therapy. Management of bleeding will depend on the diagnosis, as well as the severity and bleeding location. Many adolescent females with menorrhagia can be successfully managed with a combination of hormonal control and/or antifibrinolytics. Depending on the diagnosis, treatment can also include coagulation factor replacement, blood product transfusion, as well as specific therapies for acquired bleeding disorders, such as intravenous immune globulin, plasmapheresis, or corticosteroids.

AB - Heavy menstrual bleeding is the most common sign of an acquired or inherited bleeding disorder in females. For many young women, the manifestations of an inherited bleeding disorder do not surface until menarche, which can lead to a delay in diagnosis. Besides heavy menstrual bleeding, patients can have menstrual pain from bleeding into the corpus luteum, bleeding from trauma or procedures, easy bruising, and gastrointestinal bleeding. An undiagnosed bleeding disorder can lead to severe blood loss, chronic iron deficiency, and unnecessary surgical procedures, such as a hysterectomy. Therefore, identifying a possible bleeding disorder in these young women is crucial to allow an initiation of targeted therapy. Management of bleeding will depend on the diagnosis, as well as the severity and bleeding location. Many adolescent females with menorrhagia can be successfully managed with a combination of hormonal control and/or antifibrinolytics. Depending on the diagnosis, treatment can also include coagulation factor replacement, blood product transfusion, as well as specific therapies for acquired bleeding disorders, such as intravenous immune globulin, plasmapheresis, or corticosteroids.

KW - Adolescent

KW - Factor deficiency

KW - Hemophilia carrier

KW - ITP

KW - Menorrhagia

KW - Platelet dysfunction

KW - TTP

KW - Von willebrand disease

KW - VWD

UR - http://www.scopus.com/inward/record.url?scp=85037817037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037817037&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-17798-4_84

DO - 10.1007/978-3-319-17798-4_84

M3 - Chapter

AN - SCOPUS:85037817037

SN - 9783319177977

VL - 1

SP - 121

EP - 134

BT - Handbook of Gynecology

PB - Springer International Publishing

ER -